Navigation Links
23andMe receives NIH funding to evaluate web-based research on the genetics of drug response
Date:12/16/2010

effects and drug effectiveness experienced directly by 23andMe's customers. During the second phase, the research team will determine whether this approach enables them to replicate previously known associations between response to these three classes of drugs and variation within two genes: CYP2C9 and CYP2C19. 23andMe's research team will also search for previously unknown genetic factors associated with response to these classes of drugs, taking into consideration a broad range of non-genetic factors such as age, sex, and body-mass index, among others.

In previous studies, 23andMe has demonstrated that self-reported information from customers yields data of quality comparable to that gathered using traditional research methods. Additional benefits of 23andMe's web-based research model include: the ability to perform hundreds of studies in parallel; easy and efficient ways to contact individual participants multiple times and ask follow-up questions -- this enables 23andMe researchers to quickly zero-in on associations that could be the building blocks for future research aimed at prevention, better treatments, and potentially cures for a multitude of diseases and conditions. A web-based research model also affords participants added flexibility, they can choose when and where to respond to surveys and may take breaks to check on answers to specific questions as needed. The geographic location of research participants and their proximity to a research center is no longer a limiting factor with a web-based approach, providing an even larger pool of potential research participants.

Ultimately, web-based data collection, parallel analysis of hundreds of traits and diseases, and highly automated genotyping lead to low cost research. 23andMe's more than 60,000 customers are invited regularly to participate in a range of research projects; eligible and consenting customers will be invited to join this study during 2011.


'/>"/>

Contact: Jane E. Rubinstein
jrubinstein@rubenstein.com
212-843-8287
23andMe Inc.
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Forest Service researcher receives prestigious Presidential award
2. Epilepsy researcher at the Childrens Hospital of Philadelphia receives scientific prize
3. Boston University School of Medicine professor receives AACCs Van Slyke Award
4. Montana State University paleontologist receives major award for protecting fossils on federal land
5. Physicist Franz Pfeiffer receives 2011 Leibniz Prize
6. Pitt researcher receives NIH funding for technology-enhanced weight-loss program
7. MU plant genome research receives $3 million boost from National Science Foundation
8. VaxTrac Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
9. Don Detmer, M.D., receives 2010 Morris F. Collen Award
10. Karl Deisseroth of Stanford University receives HFSP Nakasone Award
11. Einstein researcher receives American Cancer Society Medal of Honor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
23andMe receives NIH funding to evaluate web-based research on the genetics of drug response
(Date:8/17/2015)... , Aug. 17, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... new sales campaign for Q4 2015. The new marketing ... team consisting of Amplitude Marketing Group ( http://amplitudemarketing.com/ ) ... Group is a leader in retail driven marketing and ...
(Date:8/12/2015)... 12, 2015 As the digital ... innovation and advanced biometrics technology is accelerating beyond expectations.  ... rely on using their credit cards, the digital currency, ... for payment services led by companies in the space ... Google, Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ...
(Date:8/12/2015)... 12, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that four of its fingerprint ID ... officially been named FIDO Certified™ by the Fast ... certification, Synaptics, Natural ID™ fingerprint solutions are fully ... (UAF) standard and are interoperable among other products ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
... 2012; Wiley-Blackwell, the scientific, technical, medical and scholarly publishing ... two new interdisciplinary review publications: WIREs Developmental Biology ... WIREs Developmental Biology will focus on ... fully patterned adult organism. Edited by John C. Gerhart ...
... for Molecular Medicine (MDC) Berlin-Buch and of the Excellence Cluster ... the Helmholtz Association over the next two years. The grant ... to treat diseases that are caused by protein misfolding. These ... by the MDC, a member institution of the Helmholtz Association, ...
... BOSTON (February 23, 2012, 5:00 pm ET) Researchers ... in vitro and in vivo study, published today in ... stimulates the growth of blood vessels and promotes re-growth of ... new treatment for chronic and acute wounds. The ...
Cached Biology News:Wiley-Blackwell launches 2 interdisciplinary review titles in developmental and membrane biology 2Accelerated search for active agents to treat Alzheimer's and Parkinson's 2Novel bioactive peptides promote wound healing in vivo 2Novel bioactive peptides promote wound healing in vivo 3
(Date:9/2/2015)... Sept. 2, 2015 Veracyte, Inc. (NASDAQ: ... , president and chief executive officer, will present at ... 16, 2015 at 10:30 a.m. ET in ... live audio webcast and subsequent replay may be accessed ... be available shortly after conclusion of the presentation and ...
(Date:9/2/2015)... , September 2, 2015 BiondVax Pharmaceuticals ... the National Institute of Allergy and Infectious Diseases (NIAID), part ... Department of Health and Human Services (HHS), to launch a ... the United States in the 2015-16 timeframe. The ... candidate, Multimeric-001 (M-001), as a primer vaccine, which would be ...
(Date:9/2/2015)... Orange, California (PRWEB) , ... September 02, 2015 ... ... been a critical demand to aid high-risk surgeries. From vital sign monitoring in ... powered by Intel technology enables surgeon to make real-time clinical decisions with simultaneous ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry Recycling's new ... waste to energy process and continue to contribute to the sustainability of our ... Waste to Energy process has been operating at their Mexico facility, Recicladora Temarry, ...
Breaking Biology Technology:Veracyte to Present at Morgan Stanley Global Healthcare Conference 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2
... Dec. 21 Today, Jazz,Pharmaceuticals, Inc. (Nasdaq: ... Drug,Administration (FDA) has issued an approvable letter for ... Jazz,Pharmaceuticals and Solvay Pharmaceuticals, Inc. are seeking marketing,approval ... anxiety,disorder (SAD) and obsessive compulsive disorder (OCD)., ...
... (Nasdaq: TPPH ) today announced that it received,notice ... that the minimum,bid price of its common stock had ... Tapestry was therefore not in compliance with,Marketplace Rule 4310(c)(4). ... until June 16, 2008, which is 180 calendar days,from ...
... WALTHAM, Mass., Dec. 21 Inverness Medical,Innovations, ... that it has completed its,previously announced acquisition ... is a leading provider of innovative, consumer-,centric ... facilitate,better health choices for acutely ill and ...
Cached Biology Technology:FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD) 2Tapestry Receives Notice Regarding Minimum Bid Price Rule 2
... be difficult to achieve in many bacterial ... or more restriction and modification (R-M) systems ... as "foreign". TypeOne™ Restriction Inhibitor provides a ... bacterial strains with type I R-M systems. ...
... a magnetic bead-based PCR purification ... transfer, centrifugation or filtration steps. ... large PCR extension products in ... AMPure can easily be performed ...
... is designed for the fast and simple ... at any position (for the generation of ... is designed to allow neomycin / kanamycin ... combines a prokaryotic promoter (gb2) for expression ...
... 1.5L PYREX trypsinizing flasks are ... samples into cell suspensions by ... beaded neck accepts cotton plugs. ... agitation. • Height of Baffles ...
Biology Products: